1. Home
  2. TG vs CDXS Comparison

TG vs CDXS Comparison

Compare TG & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.89

Market Cap

262.4M

Sector

Industrials

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.57

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
CDXS
Founded
1988
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Major Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
262.4M
256.3M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
TG
CDXS
Price
$7.89
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
157.8K
1.5M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
43.82
EPS
0.34
N/A
Revenue
$800,821,000.00
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
N/A
$14.24
P/E Ratio
$23.47
N/A
Revenue Growth
8.29
32.30
52 Week Low
$6.25
$0.96
52 Week High
$10.53
$3.12

Technical Indicators

Market Signals
Indicator
TG
CDXS
Relative Strength Index (RSI) 51.29 38.78
Support Level $7.24 $1.57
Resistance Level $8.20 $1.92
Average True Range (ATR) 0.36 0.08
MACD 0.04 0.04
Stochastic Oscillator 31.84 69.64

Price Performance

Historical Comparison
TG
CDXS

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: